A Tennessee man has filed a federal lawsuit blaming his diagnosis of interstitial nephritis on the popular heartburn drug, Nexium. Charles Bowers, plaintiff, says he began regular use of the drug in July, 2003 and continued until May, 2008 until the time he was diagnosed with the chronic disease. Bowers is currently undergoing dialysis treatment three times a week while awaiting a kidney transplant.
AstraZeneca, the manufacturer of the drug, has been accused of downplaying the risk of nephritis as well as other long-term kidney related side effects. Nexium was first linked to nephritis in 2004, yet the label was not changed indicating the potential danger until 2014.
Read the filing in the U.S. District Court for the Western District of Tennessee – Case No. 2:16-cv-02549 here.